BiotechTube
Home/hikma/Hafrun Fridriksdottir
HF

Hafrun Fridriksdottir

President, Rx and R&D

hikma

Roles

President, Rx and R&Dathikma
Executive Vice President, Global R&DatTeva
President, Rx and R&DatHikma Pharmaceuticals

Therapeutic Areas

Oncology Supportive CareInfectious DiseaseCentral Nervous SystemCardiovascularDiabetesPain ManagementRespiratory

hikma Pipeline

DrugIndicationPhase
Authorized Generic of Nucynta® ER (tapentadol)Pain ManagementLaunched
Authorized Generic of Nucynta® (tapentadol)Pain ManagementLaunched
Complex Generic Injectables PortfolioVarious (Oncology Support, Anti-infectives, CNS)ANDA Filed / Development
Oral Solid Dose Generics PortfolioVarious (CV, CNS, Diabetes)ANDA Pending / Development
Branded Specialty Portfolio (MENA)Oncology, Diabetes, Cardiovascular, RespiratoryMarketed / Line Extensions

Leadership Team at hikma

SD
Said Darwazah
Chief Executive Officer
FD
Faisal Darwazeh
Vice President, Group Business Development & Alliances
NR
Nassim Rahmani
Associate Vice President, Commercial Europe & Canada
RG
Roberto Gagliano
General Manager, Hikma Italia
TD
Tiago Duarte
Associate Vice President, CMO & Operations, Injectables Division
View full hikma profile